Rigel Pharmaceuticals, Inc. (RIGL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)

RIGL 38.78

+37.0%

10:19 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (406)	12/30/2008 1:38:28 PM
From: mcbio	of 566

I should also mention Accutane. The drug causes very serious birth defects but that did not stop the drug from being approved and a commercial success. I think one could argue that R788 targets a more dire patient population (RA, lymphoma, etc.) than does Accutane (acne) and therefore might be afforded even more leeway in terms of safety.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next